ArticleJournal of orthopaedic surgery and research2025
Full-endoscopic posterior lumbar interbody fusion for the treatment of lumbar degenerative diseases: a technical note with 2-year follow-up.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- [Comparison of effectiveness between two endoscopic lumbar interbody fusion techniques and minimally invasive transforaminal lumbar interbody fusion for single-level lumbar degenerative disease].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026Article
- Innovative method for efficient placement of a working cannula in uniportal transarticular full-endoscopic lumbar interbody fusion: transarticular trephonic plasty (TTP).BMC musculoskeletal disorders · 2026Article
- The impact of preoperative anticoagulant administration on postoperative coagulation function and blood loss following posterior lumbar interbody fusion: a case-control study.Frontiers in medicine · 2026Article
- Prolonged irrigation time in endoscopic aqueous medium impairs MSC/β-TCP adhesion and osteogenic potential.Scientific reports · 2025Article
- Comparative clinical outcomes of full-endoscopic posterior lumbar interbody fusion, biportal endoscopic posterior lumbar interbody fusion, and conventional posterior lumbar interbody fusion in the treatment of lumbar degenerative diseases.Frontiers in surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe spinal endoscopic technique has been extensively documented in decompression procedures for treating lumbar degenerative diseases. However, there is limited literature on the spinal endoscopic in lumbar fusion techniques. This study evaluates the outcomes and safety of full-endoscopic posterior lumbar interbody fusion (Endo-PLIF) for the treatment of lumbar degenerative diseases.
methodsA retrospective case series was conducted at Beijing Chaoyang Hospital, Capital Medical University, involving 43 patients who underwent Endo-PLIF between February 2020 and March 2021, with a minimum follow-up period of two years. Clinical outcomes were evaluated using the Visual Analog Scale (VAS), Oswestry Disability Index (ODI), and modified MacNab criteria. VAS and ODI scores were analyzed using one-way analysis of variance (ANOVA) at preoperative, 3-month, 12-month, 24-month, and final follow-up time points. Paired t-tests were employed to compare imaging parameters, including lumbar lordosis, disc height, segmental lordosis, and foraminal area, between the preoperative and final follow-up assessments.
resultsThis study included 43 consecutive patients with a mean age of 60.7 years and an average symptom duration of 4.6 years. All surgical procedures were successfully completed, with a mean operation duration of 233.8 ± 38.6 min. Mean VAS and ODI scores showed significant improvements postoperatively, decreasing from 7.05 ± 3.05, 7.44 ± 2.95, and 67.52 ± 9.31 points preoperatively to 1.22 ± 0.54, 1.50 ± 0.42, and 20.42 ± 3.57 at the latest follow-up (p < 0.001). Disc height (p = 0.012) and foraminal area (p = 0.013) increased significantly. MacNab evaluation indicated 90.6% of patients had good to excellent outcomes. Three patients experienced symptomatic nerve root irritation.
conclusionEndo-PLIF is safe and effective in the treatment of patients with lumbar degenerative disease in early follow-up. However, further extensive, long-term, multicenter studies are necessary to validate these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.